CD8+ AOIs were selected according to a location-based strategy, with CD8 infiltrate segments selected from T-cells completely inside tumor cell islets, CD8 boundary segments selected from T-cells in contact or in close proximity to tumor-stroma boundary, and CD8 distant segments consisting of T-cell clusters not in contact with tumor cell islets. Here, CD8A is linked to neoplasm.